Saneca Pharmaceuticals Overview
- Year Founded
-
1940
- Status
-
Acquired/Merged
- Employees
-
600
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
2
Saneca Pharmaceuticals General Information
Description
Manufacturer of active pharmaceutical ingredients (APIs) and finished dosage forms based in Hlohovec, Slovakia. The company specializes in developing a variety of pharmaceutical ingredients and finished dosage forms with the help of a wide range of technology and an experienced team which develops sophisticated formulations, enabling pharmacies to receive the timely delivery of products that enhance patient compliance and product effectiveness.
Contact Information
Website
www.saneca.com(Operating Subsidiary)
Corporate Office
- Nitrianska 100
- Hlohovec, 920 27
- Slovakia
Corporate Office
- Nitrianska 100
- Hlohovec, 920 27
- Slovakia
Saneca Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Saneca Pharmaceuticals Patents
Saneca Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3713911-A1 | Method for the preparation of tapentadol and its intermediates | Inactive | 18-Aug-2017 | ||
| WO-2019035775-A1 | Method for the preparation of tapentadol and its intermediates | Inactive | 18-Aug-2017 | ||
| WO-2019081972-A1 | A method for preparing mandelic acid 4-nitrophenyl ethylamide from 4-nitrobenzyl cyanide | Inactive | 09-Aug-2017 | ||
| AU-2018297073-A1 | Process for the preparation of morphinane compounds | Inactive | 04-Jul-2017 | ||
| EP-3649131-A1 | Process for the preparation of morphinane compounds | Inactive | 04-Jul-2017 | C07D489/08 |
Saneca Pharmaceuticals Signals
Saneca Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Saneca Pharmaceuticals Investments & Acquisitions (2)
Saneca Pharmaceuticals’s most recent deal was a Merger/Acquisition with Stada Production Ireland. The deal was made on 23-Jun-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Stada Production Ireland | 23-Jun-2015 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Indulona | 01-Jan-2015 | Buyout/LBO | Personal Products |
Saneca Pharmaceuticals Exits (1)
Saneca Pharmaceuticals’s most recent exit was on 01-Jan-2015 from Indulona. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Indulona | 01-Jan-2015 | Completed |
|
Saneca Pharmaceuticals FAQs
-
When was Saneca Pharmaceuticals founded?
Saneca Pharmaceuticals was founded in 1940.
-
Where is Saneca Pharmaceuticals headquartered?
Saneca Pharmaceuticals is headquartered in Hlohovec, Slovakia.
-
What is the size of Saneca Pharmaceuticals?
Saneca Pharmaceuticals has 600 total employees.
-
What industry is Saneca Pharmaceuticals in?
Saneca Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Saneca Pharmaceuticals a private or public company?
Saneca Pharmaceuticals is a Private company.
-
What is Saneca Pharmaceuticals’s current revenue?
The current revenue for Saneca Pharmaceuticals is .
-
How much funding has Saneca Pharmaceuticals raised over time?
Saneca Pharmaceuticals has raised $2.72M.
-
Who are Saneca Pharmaceuticals’s investors?
Middle Europe Investments, Sanofi, Slovak Ministry of Education, Science, Research and Sport, Wood & Company, and Zentiva Group have invested in Saneca Pharmaceuticals.
-
When was Saneca Pharmaceuticals acquired?
Saneca Pharmaceuticals was acquired on 01-Aug-2022.
-
Who acquired Saneca Pharmaceuticals?
Saneca Pharmaceuticals was acquired by AZC Services.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process